Chime Financial (CHYM) Climbs +45.5% in 30 Days on Earnings Beat and Raised Guidance
Key Takeaways
- CHYM shares advanced about 45.5% over the 30 days through the Aug. 18, 2026 close, rising from $21.93 on July 20 to $31.91.
- The move was driven by second-quarter results that beat expectations and by raised full-year guidance.
- Q2 revenue increased 27% year over year to roughly $670 million, while adjusted EBITDA reached $102 million at a 15% margin.
- Chime posted its second consecutive quarter of GAAP net income and grew active members 20% year over year to 10.4 million.
- The trailing three-month trend is even stronger, with shares up roughly 89% from the May 19 close.
Company Overview and Market Position
Chime Financial, Inc. is a San Francisco-based financial technology company that provides digital consumer banking and payment services through its proprietary platform in partnership with third-party banks. Its product ecosystem includes spending and checking accounts, a debit card, fee-free overdraft through SpotMe, MyPay earned-wage access, Instant Loans, a Credit Builder card, high-yield savings, Pay Anyone, Chime Workplace, and the recently launched Chime Invest. Chime completed its initial public offering on the Nasdaq on June 12, 2025. With 10.4 million active members at the end of June 2026, the company positions itself as a primary-account alternative to traditional banks, emphasizing lower cost-to-serve and deeper member engagement across a growing suite of financial products.
Stock Price Performance: Last 30 Days vs. Quarter
CHYM closed at $31.91 on Aug. 18, 2026, up 1.5% for the session. Thirty calendar days earlier, the stock closed at $21.93 on July 20, 2026, which translates to a gain of approximately 45.5% over the period. The advance was not linear: shares climbed into the Aug. 5 earnings report, then jumped about 20.6% on Aug. 6, from $25.92 to $31.25, on volume of roughly 19.3 million shares compared with a typical daily average near 6 million. The Aug. 6 session also produced an intraday high of $33.41, which stands as the 52-week high.
The quarterly picture is even more pronounced. From the May 19 close of $16.91 to the Aug. 18 close of $31.91, CHYM gained about 88.7%. The shares set a 52-week intraday low of $15.88 on June 11 before recovering, so the three-month move reflects both a rebound from depressed levels and a post-earnings re-rating. I also checked this using Tickeron’s AI Pattern Search Engine to see how the move compared with similar post-earnings patterns in the sector.
What Drove the 30-Day Move
The dominant catalyst was Chime's second-quarter earnings report, released Aug. 5. Revenue rose 27% year over year to $669.8 million, ahead of consensus estimates near $641 million. Adjusted EBITDA reached $102 million, with the adjusted EBITDA margin expanding 12 percentage points year over year to 15%, and the company reported $28 million in GAAP net income, its second consecutive quarter of positive GAAP earnings.
Management also raised its full-year outlook, citing accelerating momentum. Chime now projects 25% to 26% revenue growth for 2026 and adjusted EBITDA between $465 million and $475 million. For the third quarter, the company guided to revenue of $680 million to $690 million and adjusted EBITDA of $105 million to $110 million.
Product momentum reinforced the earnings story. Chime Prime, launched in early April for members with at least $3,000 in monthly qualifying direct deposits, has drawn higher-income consumers and Prime members generate more than double the average member ARPAM. MyPay originations reached $4.5 billion with transaction profit tripling year over year to $73 million, while Instant Loans originations grew nearly 70% quarter over quarter to $300 million. Chime also announced enterprise wins with Allied Universal, which has about 320,000 North American employees, and a national retailer with roughly 35,000 employees.
What Drove Performance Over the Last Quarter
Over the trailing three months, the narrative shifted from post-IPO skepticism to profitable growth. After going public in June 2025, Chime shares traded below their IPO price into spring 2026, pressured by questions about the company's path to consistent profitability. The company answered those questions first with its initial GAAP quarterly profit in Q1 2026 and then with a stronger Q2, turning investor attention toward operating leverage, transaction profit, and member monetization.
Broader product expansion also supported the quarterly trend. The April launch of Chime Prime, the July introduction of Chime Invest, higher MyPay limits, and a $500 million warehouse facility arranged with Goldman Sachs all contributed to a growth-oriented narrative. The combination of accelerating revenue, expanding margins, and consecutive profitable quarters helped CHYM nearly double from its mid-May levels.
What Investors Should Watch Next
Investors should monitor whether Chime can sustain its raised growth and profitability targets. The next quarterly report is estimated for early November 2026, and execution against the company's third-quarter guidance will be a key test. The ramp of Chime Prime, including rewards-cost moderation, will be closely watched alongside the rollout of higher MyPay limits of up to $1,000, which management said could modestly lift loss rates before being offset by higher transaction profit.
Other factors include the Instant Loans run-rate target of more than $100 million exiting Q3, the beta launch of a revolving line of credit, Chime Invest adoption, and the enterprise pipeline, which is expected to contribute more meaningfully to direct-depositor growth in 2027. Macroeconomic and consumer-spending conditions, regulatory oversight, and the announced CFO transition also remain important monitoring points for the stock. From what I see, tracking these elements will help clarify whether the recent re-rating holds.
Exploring Tickeron AI Trading Bots
In my own research process, I often turn to Tickeron’s AI Trading Bots to test quantitative strategies across different timeframes and risk profiles. The platform lets users review top-performing bots that trade thousands of tickers, helping filter for approaches that align with current market conditions rather than relying on a single signal. I find it useful for comparing rule-based ideas alongside traditional fundamental analysis, especially when evaluating momentum names like CHYM. AI Trading Bots provides a practical way to explore these options without committing capital upfront.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
CHYM in upward trend: price may jump up because it broke its lower Bollinger Band on September 16, 2026
CHYM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 6 of 7 cases where CHYM's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 86%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +3.98% 3-day Advance, the price is estimated to grow further. Considering data from situations where CHYM advanced for three days, in 50 of 63 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
The Aroon Indicator entered an Uptrend today. In 35 of 43 cases where CHYM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 81%.
Bearish Trend Analysis
The 10-day RSI Indicator for CHYM moved out of overbought territory on September 01, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 5 similar instances where the indicator moved out of overbought territory. In 4 of the 5 cases, the stock moved lower in the following days. This puts the odds of a move lower at 80%.
The Momentum Indicator moved below the 0 level on September 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CHYM as a result. In 14 of 18 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.
The Moving Average Convergence Divergence Histogram (MACD) for CHYM turned negative on August 26, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 8 similar instances when the indicator turned negative. In 7 of the 8 cases the stock turned lower in the days that followed. This puts the odds of success at 88%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHYM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 34 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. CHYM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 53 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.177) is normal, around the industry mean (51.950). P/E Ratio (5.648) is within average values for comparable stocks, (82.426). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.152). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (4.916) is also within normal values, averaging (70.180).
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CHYM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry PackagedSoftware
Advertisement